The Vaccine Battle Rages! Years ago, people did not question vaccinations so much, but today, we are in the information age. We have spent our entire lives in the “Fake News” era, but now we have the resources to find the facts for ourselves. Those of us who have woken up have discovered that the corporate cog has brainwashed us for many years. Big business rules the world, and we have been lied to all along in so many ways. Profits are more important than health and safety. The corporate conglomerate cares nothing about us.
The is an Abundance of Evidence that the influenza vaccine is extremely ineffective in people over 65.
The available evidence relating to complications is of poor quality, insufficient, or old and provides no clear guidance for public health regarding the safety, efficacy, or effectiveness of influenza vaccines for people aged 65 years or older. Society should invest in research on a new generation of influenza vaccines for the elderly.
Older adults receiving the influenza vaccine may experience less influenza over a single season, from 6% to 2.4%, meaning that 30 people would need to be vaccinated with inactivated influenza vaccines to avoid one case of influenza.
“The available evidence is of poor quality and provides no guidance regarding the safety, efficacy or effectiveness of influenza vaccines for people aged 65 years or older.”
Identify, retrieve, and assess all studies evaluating the effects of vaccines against influenza in healthy adults.
Influenza vaccines have a modest effect in reducing influenza symptoms and working days lost. There is no evidence that they affect complications, such as pneumonia or transmission.WARNING: This review includes 15 out of 36 trials funded by industry (four had no funding declaration). An earlier systematic review of 274 influenza vaccine studies published up to 2007 found industry-funded studies were published in more prestigious journals and cited more than other studies independently from methodological quality and size.
Studies funded from public sources were significantly less likely to report conclusions favorable to the vaccines. The review showed that reliable evidence on influenza vaccines is thin, but there is evidence of widespread manipulation of conclusions and spurious notoriety of the studies. The content and conclusions of this review should be interpreted in light of this finding.
Possible Toxic Reactions to the Flu Shot
- Guillain-Barré Syndrome
- Severe conditions of brain inflammation
- Autoimmune Diseases
- Bell’s palsy
- Limb paralysis
- Multiple Sclerosis
- Parkinson’s Disease
- Alzheimer’s Disease
- ALS (commonly known as Lou Gehrig’s disease).
The following ingredients found in the flu vaccine:
- Formaldehyde: In view of its widespread use, toxicity, and volatility, formaldehyde poses a significant danger to human health. In 2011, the US National Toxicology Program described formaldehyde as “known to be a human carcinogen.”
- Thimerosal/Mercury: Exposure to mercury causes damage to the kidneys and brain and is associated with inflammatory diseases like autoimmune disorders. Although methylmercury (meHg) is considered a hazardous substance that is to be avoided even at small levels when consumed in foods such as seafood and rice (in Asia), the World Health Organization considers small doses of thimerosal safe regardless of multiple/repetitive exposures to vaccines that are predominantly taken during pregnancy or infancy.
- Egg Protein: Numerous studies have demonstrated that food proteins contained in vaccines/injections induce food allergy. The increase in vaccines with food proteins has caused the food allergy epidemic.
- Sucrose and Gelatin: Gelatin is a protein that can cause allergic reactions and anaphylaxis.
- Aluminum salts: Aluminum in adjuvant form carries a risk for autoimmunity, long-term brain inflammation, and associated neurological complications and may thus have profound and widespread adverse health consequences. Aluminum has been clinically shown to cause neurological disease, autoimmunity, and multiple sclerosis.
- Neomycin: Like any other antibiotic, neomycin reduces bacteria in the gut and is associated with weakened immunity. Neomycin is also associated with causing an allergic reaction, impairing hearing and nerve function, and is kidney damage.
- Monosodium Glutamate (MSG): Similar to most vaccine ingredients that have not been tested separately for safety, the long-term cumulative effects of injecting MSG into the body and how it interacts with other chemicals and ingredients in vaccines is not known. MSG is associated with cell damage and cognitive decline.
- Polysorbate 80: Polysorbate 80 opens up the blood-brain barrier, which allows toxins into the brain that would normally not be able to enter. It has been shown to be connected to infertility.
In immunology, an adjuvant is a substance that potentiates and/or modulates the immune responses to an antigen to improve them. The word “adjuvant” comes from the Latin word adiuvare, meaning to help or aid. “An immunologic adjuvant is defined as any substance that acts to accelerate, prolong, or enhance antigen-specific immune responses when used in combination with specific vaccine antigens.”
Pertussis toxin and aluminum compounds act as adjuvants. These adjuvants are known to bias for IgE synthesis. Injecting food proteins along with these adjuvants increases the immunogenicity of the food proteins that are present in the vaccines. With up to five shots administered simultaneously, numerous food proteins and adjuvants get injected at one time. This increases the probability of sensitization.
Atsuko et al.  not only accepted that vaccine antigens and vaccine components induced allergies, but they also acknowledge the role of aluminum in IgE synthesis. Hence they worked on an alternative to aluminum-based adjuvants.
Effect of adjuvants in vaccinations
There are many adjuvants, some of which are inorganic (such as alum) that also carry the potential to augment immunogenicity. Two common salts include aluminium phosphate and aluminium hydroxide. These are the most common adjuvants in human vaccines.
The precise mechanism of alum action remains unclear, but a few insights have been gained. For instance, alum can trigger dendritic cells (DC) and other immune cells to secrete interleukin-1β (IL-1β), an immune signal that promotes antibody production. Alum adheres to the cell’s plasma membrane and rearranges certain lipids there. Spurred into action, the DC picks up the antigen and speeds to a lymph node, where it sticks tightly to a helper T cell and presumably induces an immune response. A second mechanism depends on alum killing immune cells at the injection site, although researchers aren’t sure exactly how alum kills these cells. It has been speculated that the dying cells release DNA, which serves as an immune alarm. Some studies found that DNA from dying cells causes them to adhere more tightly to helper T cells, which ultimately leads to an increased release of antibodies by B cells. No matter what the mechanism is, alum is not a perfect adjuvant because it does not work with all antigens (e.g., malaria and tuberculosis).
Dendritic cells (DCs) are antigen-presenting cells of the mammalian immune system. Their main function is to process antigen material and present it on the cell surface to the T cells of the immune system. They act as messengers between the innate and the adaptive immune systems.
Cytokines are a broad and loose category of small proteins that are important in cell signaling. Their release has an effect on the behavior of cells around them. It can be said that cytokines are involved in autocrine signaling, paracrine signaling, and endocrine signaling as immunomodulating agents. Their definite distinction from hormones is still part of ongoing research. Cytokines may include chemokines, interferons, interleukins, lymphokines, and tumor necrosis factors but generally not hormones or growth factors. Cytokines are produced by a broad range of cells, including immune cells like macrophages, B lymphocytes, T lymphocytes, and mast cells, as well as endothelial cells, fibroblasts, and various stromal cells; a given cytokine may be produced by more than one type of cell.
Some information about our next cancer treatment article.
- Complete response (CR): The tumors shrink away to the point that they are no longer detectable by physical examination, imaging studies (MRI, CT scan, etc.), or tumor markers. Obviously, this is the best possible result. This is further divided into a pathological complete response, which means that there are no detectable tumor cells in the resected tumor specimen. Obviously, when this happens, it is a very good thing and a very good prognostic sign. Sadly, it is not seen that often in clinical trials.
- Partial response (PR): This is usually defined to mean that the tumors shrink by more than 50% (or, in the case where tumor volume cannot be measured easily, tumor markers fall by more than 50%) in response to therapy but remain detectable. More recent definitions have at times loosened this criterion to include tumors that shrink by 30% or more. Whatever the specific criteria used, a certain degree of tumor shrinkage, or evidence of tumor regression, defined before the clinical trial, must be observed.
- Stable disease (SD): The tumors either shrink by less than the criteria for a PR or remain the same size. In some trials, this definition may be broadened to include tumors that increase in size slightly during therapy by less than, depending on the trial, 0-25%, although I’ve personally always been suspicious of calling any detectable growth above random variation in imaging measurements “stable.”
- Progressive disease (PD): Tumors increase in size on therapy and/or new metastatic tumors appear. This is obviously strong evidence that in that patient the therapy did not work.
Preliminary Findings on the Use of Targeted Therapy with Pazopanib and Other Agents in Combination with Sodium Phenylbutyrate in the Treatment of Glioblastoma Multiforme
Journal of Cancer Therapy
Vol.05 No.14(2014), Article ID:52600,14 pages